Edition 7 – Benefit-Risk at a time of COVID-19 and Brexit
Posted on: Thursday 12 November 2020
Autumn/Winter 2020 edition
Lead Article
Vaccines Safety During Accelerated Research and Development
By Penny Ward FFPM
In a public health emergency, the urgent need for an effective vaccine must be balanced against potential for vaccine related harms to ensure appropriate use. How can this be achieved when developing a vaccine at ‘warp speed’?
Editions of the JFPM
![](/wp-content/uploads/2020/11/jack-anstey-rEMlN5EmZ9I-unsplash-385x250.jpg)
Edition 7 – Benefit-Risk at a time of COVID-19 and Brexit
Featuring articles from Penny Ward, Saad Shakir, Alastair Benbow and many more.
![](/wp-content/uploads/2020/06/jeshoots-com-l0j0DHVWcIE-unsplash-385x250.jpg)
Edition 6 – Celebrating the ‘WHO Year of the Nurse and Midwife’
Celebrating the ‘WHO Year of the Nurse and Midwife’ through their role in pharma, plus more news and reflections